Jesse J. Geiger - Mar 4, 2024 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role
President
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Jesse J. Geiger
Stock symbol
MEDP
Transactions as of
Mar 4, 2024
Transactions value $
-$5,370,033
Form type
4
Date filed
3/6/2024, 04:42 PM
Previous filing
Mar 1, 2024
Next filing
Aug 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDP Common Stock Options Exercise $2.02M +22.3K +583.71% $90.65 26.1K Mar 4, 2024 Direct
transaction MEDP Common Stock Sale -$9M -22.3K -85.37% $403.03 3.82K Mar 4, 2024 Direct F1, F2
transaction MEDP Common Stock Options Exercise $1.6M +17.7K +462.32% $90.65 21.5K Mar 5, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEDP Employee Stock Option (Right to Buy) Options Exercise $0 -22.3K -55.8% $0.00 17.7K Mar 4, 2024 Common Stock 22.3K $90.65 Direct F3
transaction MEDP Employee Stock Option (Right to Buy) Options Exercise $0 -17.7K -100% $0.00* 0 Mar 5, 2024 Common Stock 17.7K $90.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this line of this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $401.60 to $404.525. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F3 The option vested in full on August 5, 2019.